物料
W,W,W separators
Agency
NIOSH 2514,2543,5514
产品线
Amberlite™
ORBO™
组成
Bed A, 150 mg
Bed B, 75 mg
包装
pkg of 50 ea
制造商/商品名称
ORBO™ 608
技术
active air sampling: suitable
外径 × 长度
8 mm × 110 mm
基质
XAD-2
粒径
20-50 mesh
应用
air monitoring
environmental
industrial hygiene
正在寻找类似产品? 访问 产品对比指南
一般描述
ORBO 吸附剂管（W,W,W 分离剂，O.D. × L 8 mm × 110 mm）含有两个由玻璃棉或泡沫分开的相同的选择性吸附剂床层，用于气体或蒸汽取样。吸附剂管的双层或双床层结构使得任何穿漏的样品都可以由备用床层捕集。
法律信息
Amberlite is a trademark of DuPont de Nemours, Inc.
ORBO is a trademark of Sigma-Aldrich Co. LLC
XAD is a registered trademark of The Dow Chemical Company or an affiliated company of Dow
储存分类代码
13 - Non Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Anne Beate Vereide et al.
Gynecologic oncology, 97(3), 740-750 (2005-05-12)
The aim of the study was to investigate apoptosis as a growth regulatory mechanism of gestagen in endometrial precancers and to compare differences in the apoptotic cascade after high and low dose gestagen regimens. Pre- and post-treatment paraffin-embedded endometrial hyperplasia
A Orbo et al.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 22(2), 141-148 (2003-03-22)
Derangements in the tumor suppressor gene PTEN and the mismatch-repair genes, hMLH1, hMSH2, and hMSH6, have an important role in endometrial carcinogenesis. The purpose of this study was to assess immunohistochemically the pattern of protein expression for these genes in
A Ørbo et al.
BJOG : an international journal of obstetrics and gynaecology, 123(9), 1512-1519 (2015-12-03)
To investigate relapse rates after the successful treatment of patients with non-atypical endometrial hyperplasia who were randomised to either a levonorgestrel-impregnated intrauterine system (LNG-IUS; Mirena(®) ) or two regimens of oral medroxyprogesterone acetate (MPA) after primary histological response. A multicentre
A Orbo et al.
Gynecologic oncology, 95(1), 82-88 (2004-09-24)
The purpose of the current study was to characterize the role of PTEN in malignant transformation and to evaluate the significance of mutated PTEN exons as prognostic markers in the carcinogenesis of endometrial hyperplasia. A comparison of PTEN mutations as
J P Baak et al.
The American journal of surgical pathology, 25(7), 930-935 (2001-06-23)
Prospective multicenter evaluation of the WHO classification and the morphometric D-score to predict endometrial hyperplasia cancer progression. In 132 endometrial hyperplasias WHO classification was performed by two experienced gynecologic pathologists. The D-score was assessed blindly by technicians in a routine
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持